ScienceOpen: research and publishing network

For Researchers

Search
Advanced search

0

views

    

0

recommends

0

shares

Record: found
Abstract: not found
Article: not found

Gemcitabine: current status of phase I and II trials.

Author(s): Keith S. Kaye

Publication date: 1994-07-31

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Keywords: Antimetabolites, Antineoplastic, therapeutic use, Carcinoma, Non-Small-Cell Lung, drug therapy, Clinical Trials, Phase I as Topic, Clinical Trials, Phase II as Topic, Deoxycytidine, analogs & derivatives, Drug Administration Schedule, Humans, Lung Neoplasms, Research

Read this article at

ScienceOpenPubMed

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

PubMed ID:: 8040662

ScienceOpen disciplines: Chemistry

Keywords: Antimetabolites, Antineoplastic,therapeutic use,Carcinoma, Non-Small-Cell Lung,drug therapy,Clinical Trials, Phase I as Topic,Clinical Trials, Phase II as Topic,Deoxycytidine,analogs & derivatives,Drug Administration Schedule,Humans,Lung Neoplasms,Research

Data availability:

ScienceOpen disciplines: Chemistry

Keywords: Antimetabolites, Antineoplastic, therapeutic use, Carcinoma, Non-Small-Cell Lung, drug therapy, Clinical Trials, Phase I as Topic, Clinical Trials, Phase II as Topic, Deoxycytidine, analogs & derivatives, Drug Administration Schedule, Humans, Lung Neoplasms, Research

Comments

Comment on this article

Similar content 1,746

See all similar

Cited by 10

See all cited by